Clinical Trial Update: A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination [NA]

View source ↗

Summary

A pivotal IDE study on laminar left atrial appendage elimination for non-valvular atrial fibrillation is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation
• Stroke
• Systemic Embolism

Drugs mentioned

• Laminar Left Atrial Appendage Elimination

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Non-valvular Atrial Fibrillation, Stroke | NA | Status: SUSPENDED